New cancer clinical trial: Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Published on: January 25, 2018 at 12:00PM
Condition:   Ovarian Cancer
Interventions:   Drug: Pembrolizumab;   Drug: Paclitaxel;   Drug: Carboplatin
Sponsors:   National Cancer Institute, Naples;   Mario Negri Institute for Pharmacological Research
Not yet recruiting
http://ift.tt/2ncnBPC